Akoya Biosciences at the 6th Immunotherapy of Cancer Conference (iTOC6)

April 11 – 13, 2019 | Erste Campus, Am Belvedere 1, 1100 Vienna, Austria | Booth 21

We look forward to meeting you at ITOC6 and discussing our newest innovations for spatially resolved, multiplexed immunofluorescence. Explore how the new CODEX® system (40+ biomarkers) can accelerate your biomarker discovery efforts in immuno-oncology and how the recently launched Phenoptics 2.0 solution (up to 200 slides) can simplify your multiplexed immunofluorescence workflow for translational research and clinical trial applications.

Exhibitors (Pipeline) Session | April 12, 13:05 – 13:15

Multiplex Immunofluorescence Solutions to Study the Tumor Microenvironment

Speaker: Björn Wendik, PhD, Field Application Scientist, Akoya Biosciences, Inc.

Venue: Main Lecture Hall (between the Plenary Session and lunch)

Topics to be discused:

  • Latest enhancements to Opal™ Multiplex IHC kits, Vectra® Polaris ™ System & inForm ™ Analysis software
  • Introduction to CODEX® Discovery Platform

Register Now >


Stop by our posters to see the latest data from our platforms and for a chance to have an in-depth discussion with our application scientist.

Multispectral Imaging for Quantitative and Compartment Specific Immune Profiling of Cancer Tissue

Björn Wendik, Akoya Biosciences, Inc.

About our products

Come by booth #21 and get a demo of our Vectra® Polaris™ platform and inForm® Software package for automated image analysis.

pasted image 0.png

The CODEX System

Use an existing fluorescence microscope for high-quality multiplexed tissue imaging of 40+ biomarkers.


The Vectra Polaris System

Scan whole slides within 6 minutes for 7 biomarkers with the throughput of up to 80 slides at a time


Opal IHC Staining Kits

Optimized for Vectra® and Mantra™ systems with automated staining on the BOND RX instrument from Leica Biosystems.


inForm Image Analysis Software

Automate tissue segmentation, cell phenotyping and easily separate weakly expressing and overlapping biomarkers.